<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2183-6914</journal-id>
<journal-title><![CDATA[Revista Onconews]]></journal-title>
<abbrev-journal-title><![CDATA[Revista Onconews]]></abbrev-journal-title>
<issn>2183-6914</issn>
<publisher>
<publisher-name><![CDATA[Associação de Enfermagem Oncológica Portuguesa (AEOP)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2183-69142022000100012</article-id>
<article-id pub-id-type="doi">10.31877/on.2022.44.02</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[CUIDADOS À PESSOA SUBMETIDA À ADMINISTRAÇÃO DE IODO131 COMO TERAPÊUTICA NOS TUMORES DA TIRÓIDE]]></article-title>
<article-title xml:lang="en"><![CDATA[CARE FOR THE PERSON SUBMITTED TO THE ADMINISTRATION OF IODO131 AS THERAPEUTIC IN THYROID TUMORS]]></article-title>
<article-title xml:lang="es"><![CDATA[ATENCIÓN A PERSONAS SOMETIDAS A LA ADMINISTRACIÓN DE YODO131 COMO TERAPIA EN TUMORES DE TIROIDES]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jesus]]></surname>
<given-names><![CDATA[Cristiana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[Anabela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cardoso]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Hospitalar de Leiria, Hospital de Santo André Bloco Operatório ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Português de Oncologia do Porto Clínica de Cabeça e Pescoço Tumores Endócrinos]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Português de Oncologia Coimbra Serviço de Especialidades Cirúrgicas 1 ]]></institution>
<addr-line><![CDATA[Coimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>06</month>
<year>2022</year>
</pub-date>
<numero>44</numero>
<fpage>12</fpage>
<lpage>17</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2183-69142022000100012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2183-69142022000100012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2183-69142022000100012&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: Com este artigo, pretende-se apresentar os cuidados à pessoa submetida à administração de iodo131, como terapia complementar nos tumores da tiróide. Este tratamento tem um papel preponderante na destruição de células malignas que possam restar após a cirurgia, nos cancros diferenciados da tiróide. Pela necessidade de cuidados específicos que podem ser fundamentais para o sucesso do tratamento, o enfermeiro tem aqui uma atuação fundamental na preparação da pessoa para o mesmo. A intervenção de enfermagem estende-se a todo o processo de tratamento e ao período que se segue a este, em que há necessidade de manter cuidados específicos e fundamentais para a recuperação da pessoa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: With this article, it is intended to present the care to the person submitted to the administration of iodine131, as complementary therapy in thyroid tumors. This treatment has a major role in the destruction of malignant cells that may remain after surgery, in differentiated thyroid cancers. Due to the need for specific care that can be fundamental for the success of the treatment, the nurse has a fundamental role here in preparing the person for the same. The nursing intervention extends to the entire treatment process and the period following it, when there is a need to maintain specific and fundamental care for the person's recovery.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Con este artículo pretendemos presentar los cuidados a la persona sometida a la administración de yodo131, como terapia complementaria en los tumores tiroideos. Este tratamiento juega un papel importante en la destrucción de las células malignas que pueden quedar después de la cirugía en los cánceres diferenciados de tiroides. Debido a la necesidad de unos cuidados específicos que pueden ser fundamentales para el éxito del tratamiento, la enfermera tiene un papel fundamental en la preparación de la persona para el mismo. La intervención de enfermería se extiende a todo el proceso de tratamiento y al período que le sigue, en el que se requiere mantener unos cuidados específicos y fundamentales para la recuperación de la persona.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Cancro da tiróide]]></kwd>
<kwd lng="pt"><![CDATA[Tiroidectomia total]]></kwd>
<kwd lng="pt"><![CDATA[Iodo131]]></kwd>
<kwd lng="pt"><![CDATA[Cuidados de enfermagem.]]></kwd>
<kwd lng="en"><![CDATA[Thyroid cancer]]></kwd>
<kwd lng="en"><![CDATA[Total thyroidectomy]]></kwd>
<kwd lng="en"><![CDATA[Iodine131]]></kwd>
<kwd lng="en"><![CDATA[Nursing care.]]></kwd>
<kwd lng="es"><![CDATA[Cáncer de tiroides]]></kwd>
<kwd lng="es"><![CDATA[Tiroidectomía total]]></kwd>
<kwd lng="es"><![CDATA[Yodo131]]></kwd>
<kwd lng="es"><![CDATA[Cuidado de enfermera.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campennì]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Barbaro]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Guzzo]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Capoccetti]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Giovanella]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts.]]></article-title>
<source><![CDATA[Endocrine]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="">
<collab>Globocan</collab>
<source><![CDATA[Cancer Today.]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<collab>Instituto Português de Oncologia do Porto</collab>
<source><![CDATA[Manual de Iodoterapia]]></source>
<year>2015</year>
<publisher-name><![CDATA[Serviço de Medicina Nuclear]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mamede]]></surname>
<given-names><![CDATA[A.C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Iodo 131 no Diagnóstico e Terapia do Cancro da Tiróide.]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Padma]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Sundaram]]></surname>
<given-names><![CDATA[P. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Radioiodine as an adjuvant therapy and its role in follow&#8208;up of differentiated thyroid cancer.]]></article-title>
<source><![CDATA[Journal of Cancer Research and Therapeutics]]></source>
<year>2016</year>
<volume>12</volume>
<page-range>1109-13</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="book">
<collab>Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo</collab>
<source><![CDATA[Tratamento com Iodo Radioativo no Cancro da Tiróide.]]></source>
<year>2014</year>
<publisher-name><![CDATA[Grupo de Estudos da Tiróide]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="">
<collab>Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo</collab>
<source><![CDATA[Cancro da Tiróide]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Carreira]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancro da Tiróide.]]></source>
<year>2017</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
